We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

151 hedge funds and large institutions have $934M invested in Editas Medicine in 2017 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 46 increasing their positions, 25 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

212% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 17

84% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 25

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

34% more capital invested

Capital invested by funds: $698M → $934M (+$237M)

30% more funds holding

Funds holding: 116 → 151 (+35)

0.03% less ownership

Funds ownership: 69.01% → 68.97% (-0.03%)

32% less call options, than puts

Call options by funds: $13.5M | Put options by funds: $20M

Holders
151
Holders Change
+35
Holders Change %
+30.17%
% of All Funds
3.42%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
53
Increased
46
Reduced
25
Closed
17
Calls
$13.5M
Puts
$20M
Net Calls
-$6.49M
Net Calls Change
-$3.54M

Top Buyers

1
State Street
State Street
Massachusetts
+$13.9M
2
FCM
Farallon Capital Management
California
+$13M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$11.9M
4
AIM
ARK Investment Management
Florida
+$10.7M
5
CS
Credit Suisse
Switzerland
+$6.39M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$8.5M
2
Invesco
Invesco
Georgia
-$7.96M
3
NI
Numeric Investors
Massachusetts
-$6.02M
4
GAM
Greenwoods Asset Management
Cayman Islands
-$4.37M
5
PP
Peconic Partners
New York
-$3.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$142M +$2.23M +88,604 +2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$85.1M +$11.9M +471,648 +21%
BlackRock
3
BlackRock
New York
$82.1M +$848K +33,664 +1%
State Street
4
State Street
Massachusetts
$73.9M +$13.9M +553,938 +30%
Capital World Investors
5
Capital World Investors
California
$54.4M – – –
DM
6
Deerfield Management
New York
$52.5M – – –
Viking Global Investors
7
Viking Global Investors
Connecticut
$52.5M – – –
FP
8
Flagship Pioneering
Massachusetts
$51.5M – – –
AIM
9
ARK Investment Management
Florida
$34.2M +$10.7M +424,975 +62%
TGI
10
TRV GP III
Massachusetts
$27.8M +$22.8M +906,176 New
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$27.6M -$8.5M -337,670 -27%
Morgan Stanley
12
Morgan Stanley
New York
$19.1M +$1.49M +59,083 +10%
GTP
13
Global Thematic Partners
New York
$18.9M +$1.23M +49,011 +9%
FCM
14
Farallon Capital Management
California
$15.8M +$13M +515,000 New
Millennium Management
15
Millennium Management
New York
$13M +$1.24M +49,336 +13%
CS
16
Credit Suisse
Switzerland
$11.5M +$6.39M +253,627 +208%
Northern Trust
17
Northern Trust
Illinois
$11.5M -$81.5K -3,235 -0.9%
TCIM
18
TIAA CREF Investment Management
New York
$11.3M +$2.33M +92,606 +34%
American Century Companies
19
American Century Companies
Missouri
$9.31M -$233K -9,269 -3%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$8.91M +$1.29M +51,059 +21%
Goldman Sachs
21
Goldman Sachs
New York
$8.67M -$1.41M -55,800 -17%
UBS AM
22
UBS AM
Illinois
$7.57M +$6.2M +246,201 New
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$7.53M +$926K +36,765 +18%
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$6.67M +$5.46M +216,906 New
Arrowstreet Capital
25
Arrowstreet Capital
Massachusetts
$5.35M +$3.94M +156,535 +889%
1
2 3 4 5

EDIT Hedge Fund Activity: Q4 2017 in Review

151 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2017, worth a combined $934M — up 34% from $698M a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new EDIT positions and 17 closed out — a net gain of 36 holders — while 46 added to existing stakes and 25 trimmed.

The largest buyer was State Street, adding an estimated $13.9M. The largest seller was T. Rowe Price Associates, cutting an estimated $8.5M.

  • 151 institutional investors held Editas Medicine (EDIT) as of Q4 2017, up from 116 in Q3 2017.
  • Funds reported $934M of Editas Medicine stock for Q4 2017, up 34% quarter-over-quarter.
  • 53 funds opened new Editas Medicine positions in Q4 2017 and 17 closed out, a net change of +36 holders.
  • The largest Editas Medicine buyer in Q4 2017 was State Street, an estimated $13.9M added.
  • The largest Editas Medicine seller in Q4 2017 was T. Rowe Price Associates, an estimated $8.5M sold.

Based on aggregated 13F filings for Q4 2017.